Ex parte VEL, LLC

Summary

The Alabama Supreme Court reviews a petition for a writ of mandamus challenging the denial of summary-judgment motions in a pharmacy medication-error lawsuit. The court addresses whether claims against the pharmacy owner and individual employees related back under Alabama Rules of Civil Procedure 9(h) and 15(c), and considers the plaintiffs’ arguments concerning due diligence, equitable tolling, and equitable estoppel. The opinion concludes that the plaintiffs were not ignorant of the pharmacy owner’s identity when the original complaint was filed, based on communications identifying Montgomery Drug Company, Inc.

Holdings

1. The amendment adding MDCI did not relate back under Rule 15(c)(4) because the plaintiffs were not ignorant of MDCI's identity when they filed the original complaint. The undisputed communications identifying MDCI as the insured showed that the plaintiffs knew, should have known, or were on notice that MDCI was the proper party.
2. The petitioners did not establish a clear legal right to mandamus relief concerning Stafford and Greene. The asserted one-month delay in substituting them was insufficient, on the authority presented, to establish a lack of prompt amendment, and the petitioners did not adequately show that the plaintiffs failed to exercise due diligence.
3. Equitable tolling and equitable estoppel did not prevent MDCI from asserting the statute of limitations. The record showed no extraordinary circumstance, false representation, or concealment that prevented the plaintiffs from discovering MDCI's identity.
4. The Court declined to review the petitioners' argument that VEL was entitled to summary judgment because VEL had no connection to the lawsuit. That issue did not fall within the narrow exception permitting mandamus review of a denial of summary judgment.

Questions Presented

1. Whether the amendment substituting Montgomery Drug Co., Inc. for a fictitiously named defendant related back to the original complaint under Alabama Rules of Civil Procedure 9(h) and 15(c)(4).
2. Whether the amendments substituting Robert Stafford and Erica Greene for fictitiously named defendants failed to relate back because the plaintiffs lacked due diligence or failed to amend promptly.
3. Whether equitable tolling or equitable estoppel prevented Montgomery Drug Co., Inc. from asserting the statute of limitations.
4. Whether the Supreme Court could review by mandamus the denial of VEL's summary-judgment motion based on its assertion that it had no connection to the lawsuit.

Disposition

other